ARTICLE | Company News
Pherin, Taisho deal
September 11, 2000 7:00 AM UTC
The companies signed a research and option agreement to develop and market Pherin’s vomeropherin technology in three therapeutic areas. Vomeropherins are compounds that act on the hypothalamus by stim...